Best Mass Vaccination Model, Seattle, USA

Subha Devi S; Rathinasamy  M; Rijoe Rajulin; Subham Nirala

Subha Devi S Associate Professor, Shri Sathya Sai Medical College and Research Institute, A Unit of Sri Balaji Vidyapeeth University, Ammapettai, Tamil Nadu, India.
Rathinasamy M Professor, Shri Sathya Sai Medical College and Research Institute, A Unit of Sri Balaji Vidyapeeth University, Ammapettai, Tamil Nadu, India.
Rijoe Rajulin Senior Resident, Shri Sathya Sai Medical College and Research Institute, A Unit of Sri Balaji Vidyapeeth University, Ammapettai, Tamil Nadu, India.
Subham Nirala Resident, Shri Sathya Sai Medical College and Research Institute, A Unit of Sri Balaji Vidyapeeth University, Ammapettai, Tamil Nadu, India.

Abstract

How to cite this article:
Devi. SS, Rathinasamy M, Rajulin R, Nirala S. Best
Mass Vaccination Model, Seattle, USA. Chettinad
Health City Med J. 2023;12(3):1-2.

DOI: https://doi.org/10.24321/2278.2044.202361

References

Dagan N, Barda N, Kepten E, Miron O, Perchik S, Katz MA, Hernan MA, Lipsitch M, Reis B, Balicer RD. BNT162b2 mRNA COVID – 19 vaccine in a nationwide mass vaccination setting. N Engl J Med. 2021;384(15):1412-23. [PubMed] [Google Scholar]

Hanly M, Churches T, Fitzgerald O, Caterson I, Macintyre CR, Jorm L. Modelling vaccination capacity at mass vaccination hubs and general practice clinics: a simulation study. BMC Health Serv Res. 2022;22(1):1059. [PubMed] [Google Scholar]

World Health Organisation. Framework for decision–making: implementation of mass vaccination campaigns in the context of COVID-19. Switzerland, Geneva: World Health Organisation; 2020.

Goralnick E, Kaufmann C, Gawande AA. Mass vaccination sites – an essential innovation to curb the COVID–19 pandemic. N Engl J Med. 2021;384(18):e67. [PubMed] [Google Scholar]